Gimv NV
Suletud
SektorRahandus
44.35 -0.45
Ülevaade
Aktsiahinna muutus
24h
Min
44.35
Max
44.55
Sissetulek | 127M |
|---|---|
Müük | 65M |
P/E Sektori keskmine | 8.034 41.721 |
Aktsiakasum | 3.4 |
Dividenditootlus | 5.59 |
Kasumimarginaal | 195.239 |
Töötajad | 95 |
EBITDA | 128M |
Dividenditootlus Sektori keskmine | 5.59% 4.65% |
|---|---|
Järgmine tulemuste avaldamine | 11. juuni 2026 |
Turukapital | 1.7B |
|---|---|
Eelmine avamishind | 44.8 |
Eelmine sulgemishind | 44.35 |
Uudiste sentiment
By Acuity
50%
50%
174 / 439 Pingereas Finance
Gimv NV Graafik
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
Seotud uudised
Võrdlus sarnastega
Hinnamuutus
Gimv NV Prognoos
Sentiment
By Acuity
174 / 439 Pingereas Rahandus
Uudiste sentiment
Neutral
Volatiilsus
Alla keskmise
Uudismaht (RCV)
Üle keskmise
Finantsandmed
Tegevuskulud
Maksueelne kasum
Müük
Müügikulu
Brutokasum müügist
Intressikulud võla pealt
EBITDA
Ärikasum
$
Ettevõttest Gimv NV
Gimv NV is a private equity and venture capital firm specializing in direct and fund of funds investments. For direct investments, the firm specializes in buyouts, growth capital, middle market, debt, shareholder loans, seed, startups, early to mid-stage, late venture, public to private transactions, small and medium sized enterprises, later stage, mature, replacement capital, bridge financing, and recapitalization. Within fund of funds, it seeks to invest in venture capital and private equity funds. It seeks to invest in high performance growth companies that respond to that can speed up their internal growth through acquisitions. The firm typically invests in consumer, connected consumer, fintech; health and care; smart industries; and sustainable cities. Within consumer, it seeks to provide growth capital to emerging leaders. Within health and care platform, the firm seeks to invest in companies that can grow either organically or through a buy and build strategy. Within consumer, it focuses on consumer goods, food and beverage, healthy food, sport, convenience food, personal luxury, career, home & deco, baby & kids, pet products, retail, consumer services, media and content, travel and leisure, education, digital economy and online sectors. Within health and care sector, it focuses on life sciences, medtech, and health and care services. The firm focuses on biotech/biopharma comprising drugs, platform technologies, vaccines and diagnostic tests, preclinical, early clinical, and late clinical, medtech such as medical devices, consumables, IT and small equipment, and health and care services-based companies. It also seeks to be an active shareholder, preferably lead or co-lead in its investments. Within smart industries, it focuses on equipment, services and tools for resource efficient development and production, automotive and aerospace, both optimizing of the existing and development of new means of transport, software and services harnessing the flexibility of the cloud, smart data management and advanced c
